Primary Clinical Endpoint of 12-Month Binary MACCE. [clinicaltrials_resource:NCT00114972/outcome/1]
outcome [clinicaltrials_vocabulary:outcome]
Primary Clinical Endpoint of 12-Month Binary MACCE. [clinicaltrials_resource:NCT00114972/outcome/1]
Bio2RDF identifier
NCT00114972/outcome/1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:NCT00114972/outcome/1
group [clinicaltrials_vocabulary:group]
measure [clinicaltrials_vocabulary:measure]
population [clinicaltrials_vocabulary:population]
ITT analysis
ITT analysis. Number of parti ...... as listed in Participant Flow.
safety issue [clinicaltrials_vocabulary:safety-issue]
time frame [clinicaltrials_vocabulary:time-frame]
1 month after procedure and 6 months, 1, 3 and 5 years post allocation
1 month after procedure and 6 months, 3 years, and 5 years post allocation
1 month after procedure
1 year post allocation
1 year, 3 and 5 years post allocation
12 Months post enrollment
12 months after enrollment
12 months post enrollment
3 years post allocation
type [clinicaltrials_vocabulary:type]
alternate
Primary Clinical Endpoint of 12-Month Binary MACCE.
@en
identifier
clinicaltrials_resource:NCT00114972/outcome/1
title
Number of participants at prim ...... ularization (PCI and/or CABG).
@en
type
label
Primary Clinical Endpoint of 1 ...... esource:NCT00114972/outcome/1]
@en